Dong Lyu

Corporate Officer/Principal chez Zhuhai Hillhouse Investment Management Holding Co. Ltd.

Profil

Dong Lyu currently works at Zhuhai Hillhouse Investment Management Holding Co. Ltd., as Managing Director from 2020 and Zhuhai Gao Ling Equity Investment Management Co. Ltd., as Managing Director from 2020.
Dr. Lyu also formerly worked at Genor Biopharma Holdings Ltd., as Non-Executive Director from 2021 to 2025, Shanghai Ark Biopharmaceutical Co., Ltd., as Director in 2021, Keymed Biosciences, Inc., as Non-Executive Director from 2021 to 2022, Jacobio Pharmaceuticals Group Co., Ltd., as Non-Executive Director from 2020 to 2023, Clover Biopharmaceuticals Ltd., as Non-Executive Director from 2021 to 2022, Pag Growth Zhuhai Holding Investment Management Co. Ltd., as Managing Director from 2016 to 2020, Luye Pharma Group Ltd., as Non-Executive Director from 2023 to 2025, and Shanghai Panxin Equity Investment Management Co. Ltd., as VP- Pharmaceutical & Medical Device Investment from 2011 to 2016.
Dr. Lyu received his graduate degree in 2003 from Peking University, doctorate degree in 2010 from China Pharmaceutical University, and undergraduate degree in 1996 from Beijing Medical University.

Postes actifs de Dong Lyu

Sociétés	Poste	Début
Zhuhai Hillhouse Investment Management Holding Co. Ltd.	Corporate Officer/Principal	30/09/2020
Zhuhai Gao Ling Equity Investment Management Co. Ltd.	Corporate Officer/Principal	01/09/2020

Anciens postes connus de Dong Lyu

Sociétés	Poste	Fin
EDDING GENOR GROUP HOLDINGS LIMITED	Directeur/Membre du Conseil	26/06/2025
LUYE PHARMA GROUP LTD.	Directeur/Membre du Conseil	10/03/2025
JACOBIO PHARMACEUTICALS GROUP CO., LTD.	Directeur/Membre du Conseil	31/08/2023
CLOVER BIOPHARMACEUTICALS, LTD.	Directeur/Membre du Conseil	28/10/2022
KEYMED BIOSCIENCES INC.	Directeur/Membre du Conseil	29/03/2022